Cargando…

Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study

OBJECTIVES: To evaluate spinal radiographic damage over time and to explore the associations of radiographic progression with patient characteristics and clinical assessments including disease activity in ankylosing spondylitis (AS) patients treated with tumor necrosis factor-alpha (TNF-α) blocking...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maas, Fiona, Spoorenberg, Anneke, Brouwer, Elisabeth, Bos, Reinhard, Efde, Monique, Chaudhry, Rizwana N., Veeger, Nic J. G. M., van Ooijen, Peter M. A., Wolf, Rinze, Bootsma, Hendrika, van der Veer, Eveline, Arends, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400173/ https://www.ncbi.nlm.nih.gov/pubmed/25879956 http://dx.doi.org/10.1371/journal.pone.0122693

Ejemplares similares

Higher Bone Turnover Is Related to Spinal Radiographic Damage and Low Bone Mineral Density in Ankylosing Spondylitis Patients with Active Disease: A Cross-Sectional Analysis
por: Arends, Suzanne, et al.
Publicado: (2014)

Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis
por: Maas, Fiona, et al.
Publicado: (2017)

Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors
por: Maas, Fiona, et al.
Publicado: (2017)

Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors
por: Carbo, Marlies J. G., et al.
Publicado: (2018)

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis
por: Arends, Suzanne, et al.
Publicado: (2020)

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments
por: Arends, Suzanne, et al.
Publicado: (2013)

The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study
por: Arends, Suzanne, et al.
Publicado: (2012)

After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis
por: Siderius, Mark, et al.
Publicado: (2023)

High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis
por: de Wolff, Liseth, et al.
Publicado: (2023)

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study
por: Arends, Suzanne, et al.
Publicado: (2011)

B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis
por: Wilbrink, Rick, et al.
Publicado: (2021)

The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis
por: Arends, S., et al.
Publicado: (2010)

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
por: Ramiro, Sofia, et al.
Publicado: (2013)

Social Role Participation Questionnaire for patients with ankylosing spondylitis: translation into Dutch, reliability and construct validity
por: van Genderen, Simon, et al.
Publicado: (2016)

CD27(-)CD38(low)CD21(low) B-Cells Are Increased in Axial Spondyloarthritis
por: Wilbrink, Rick, et al.
Publicado: (2021)

Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis
por: Kieskamp, Stan C, et al.
Publicado: (2021)

Predictive factors of radiographic progression in ankylosing spondylitis
por: Kim, Hyungjin, et al.
Publicado: (2015)

Serum levels of bone turnover markers including calculation of Z-scores: Data from a Dutch healthy reference cohort
por: Siderius, Mark, et al.
Publicado: (2023)

Employment and the role of personal factors among patients with ankylosing spondylitis: a Dutch cross-sectional case-control study
por: Webers, Casper, et al.
Publicado: (2018)

Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?
por: Baraliakos, X, et al.
Publicado: (2015)

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Giovanni, Orsolini, et al.
Publicado: (2018)

Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis
por: Hwang, Mark C., et al.
Publicado: (2021)

Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis
por: Nam, Bora, et al.
Publicado: (2023)

The Effects of Sex and Estrogen on Radiographic Progression of Ankylosing Spondylitis in Korean Patients
por: Jeong, Hyemin, et al.
Publicado: (2021)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Bone Morphogenetic Protein 6 Polymorphisms Are Associated with Radiographic Progression in Ankylosing Spondylitis
por: Joo, Young Bin, et al.
Publicado: (2014)

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
por: van der Heijde, Désirée, et al.
Publicado: (2009)

Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients
por: Pike, James, et al.
Publicado: (2021)

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study
por: Webers, Casper, et al.
Publicado: (2018)

Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis
por: Park, Jun Won, et al.
Publicado: (2016)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

Occult Andersson lesions in patients with ankylosing spondylitis: undetectable destructive lesions on plain radiographs
por: Huang, Ji-Chen, et al.
Publicado: (2021)

Differences of ultrasonographic enthesitis between patients with non-radiographic axial spondylarthritis and ankylosing spondylitis
por: Li, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o7h3jg2ghatr3olfr1i2kbesqg